ANDA litigation : (Registro nro. 173265)

Detalles MARC
000 -LEADER
fixed length control field 01898cam a2200409 i 4500
001 - CONTROL NUMBER
control field 2012018433
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr un ---uuuua
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120503t20122012ilu ob 001 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2012018433
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781614384786
035 ## -
-- 40481
040 ## - CATALOGING SOURCE
Original cataloging agency UtOrBLW
Language of cataloging eng
Description conventions rda
Transcribing agency UtOrBLW
042 ## -
-- pcc
043 ## -
-- n-us---
050 00 -
-- KF3133.B56
-- A86 2012
082 00 -
-- 346.7304/86
-- 23
245 00 - TITLE STATEMENT
Title ANDA litigation :
Remainder of title strategies and tactics for pharmaceutical patent litigators /
Statement of responsibility, etc Kenneth L. Dorsney, editor-in-chief.
246 30 -
-- Abbreviated New Drug Application litigation
264 #1 -
-- Chicago :
-- American Bar Association, Section of Intellectual Property Law,
-- [2012]
264 #4 -
-- ©2012
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xxiii, 809 pages)
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Statutory and regulatory scheme -- Drug approval process - an overview -- Notice and pre-filing considerations -- Litigation timeline -- Initiating litigation -- Responding to the complaint -- Discovery -- Experts -- Claim construction -- Summary judgment -- Remedies -- Settlement -- Antitrust -- Pretrial preparation -- Trial -- Post-trial -- Appeals to the court of appeals for the federal circuit -- Pharmaceutical regulation and litigation in foreign countries -- Managing an ANDA litigation.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biotechnology
Geographic subdivision United States
General subdivision Patents.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
Geographic subdivision United States
General subdivision Patents.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Patent suits
Geographic subdivision United States.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacy
General subdivision Law and legislation
Geographic subdivision United States.
653 ## -
-- Abbreviated New Drug Application.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dorsney, Kenneth L.
856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICO
Identificador Uniforme del Recurso (URI/URL) https://app.vlex.com/#/sources/40481
942 ## -
-- RAA
999 ## -
-- 173265
-- 173265

No hay ítems disponibles.


CONTACTO


NOSOTROS


SITIOS DE INTERES

coordinacion.biblioteca.biblioteca@unienlinea.mx Misión, Visión y Objetivos Bases de datos
Directorio Bibliotecas Digitales y Repositorios
Normatividad Revistas y artículos
Convenios interbibliotecarios
Boletines



Hecho en México. Universidad Insurgentes (UIN). Todos los derechos reservados 2024. Esta página y sus contenidos pueden ser reproducidos con fines no lucrativos, siempre y cuando no se mutile, se cite la fuente completa y su dirección electrónicas. De otra forma requiere permiso previo por escrito de la institución




2024 Copyright Universidad Insurgentes | www.bibliouin.com.mx